Instrument · rotarod-test
Papers18
Papers that used this instrument, by the store's list, newest first. Each was joined to ScienceGraph's copy of PubMed by its DOI, kept where the titles agree, and checked on its open text where PMC holds it. Citations are iCite's.
1 to 18 of 18
Download this page as JSON| Paper | Venue | Year | Kind | PubMed ID | Citations | Its open text | Source |
|---|---|---|---|---|---|---|---|
| Impact of impaired endogenous neurosteroidogenesis on outcomes following chronic alcohol exposure | Alcohol | 2026 | paper | 42,119,879 | 0 | No open text on the shelf | PubMed |
| Nicotinamide Riboside Enhances Mitochondrial Bioenergetics and Dopaminergic Signaling Independent of Neuron Survival in a Double-Hit Parkinson’s Model | Research Square | 2026 | preprint | 42,370,283 | 0 | Names the maker | PubMed |
| Experimental Galactose-1-Phosphate Uridylyltransferase (GALT) mRNA Therapy Improves Motor-Related Phenotypes in a Mouse Model of Classic Galactosemia-A Pilot Study. | Biomedicines | 2025 | paper | 41,462,863 | 0 | Names the maker | PubMed |
| MICU2 controls mitochondrial calcium signaling and migration in neurons during development. | Cell Reports | 2025 | paper | 41,273,721 | 3 | Names the maker | PubMed |
| Therapeutic Treatment With OLX-07010 Inhibited Tau Aggregation and Ameliorated Motor Deficits in an Aged Mouse Model of Tauopathy | Journal of Neurochemistry | 2025 | paper | 40,052,227 | 3 | Names the maker | PubMed |
| Inhibition of Rho-Associated Kinases ROCK1 and ROCK2 as a Therapeutic Strategy to Reactivate the Repressed FXN Gene in Friedreich Ataxia. | The Journal of Neuroscience | 2025 | paper | 40,404,357 | 0 | No open text on the shelf | PubMed |
| CRISPR activation of the ribosome-associated quality control factor ASCC3 ameliorates fragile X syndrome phenotypes in mice | Science Translational Medicine | 2025 | paper | 41,061,044 | 1 | Names no maker | PubMed |
| Short-lived Niemann-Pick type C mice with accelerated brain aging as a novel model for Alzheimer’s disease research | Neural Regeneration Research | 2025 | paper | 40,313,113 | 5 | Names the maker | PubMed |
| A novel CD71 Centyrin:Gys1 siRNA conjugate reduces glycogen synthesis and glycogen levels in a mouse model of Pompe disease. | Molecular Therapy | 2025 | paper | 39,604,266 | 6 | Names the maker | PubMed |
| Targeting microRNA-dependent control of X chromosome inactivation improves the Rett Syndrome phenotype | Nature Communications | 2025 | paper | 40,615,387 | 11 | Names no maker | PubMed |
| Inhibition of GSK3α,β rescues cognitive phenotypes in a preclinical mouse model of CTNNB1 syndrome | EMBO Molecular Medicine | 2024 | paper | 39,103,699 | 7 | Names the maker | PubMed |
| ATP1A1-linked diseases require a malfunctioning protein product from one allele | Biochimica et Biophysica Acta (BBA) - Molecular Cell Research | 2024 | paper | 37,659,504 | 4 | Names the maker | PubMed |
| Small-molecule inhibition of glycogen synthase 1 for the treatment of Pompe disease and other glycogen storage disorders | Science Translational Medicine | 2024 | paper | 38,232,139 | 36 | Names the maker | PubMed |
| A deep-learning-based screening platform in aging-relevant human motor neurons to identify therapeutic compounds for amyotrophic lateral sclerosis | bioRxiv | 2023 | preprint | No open text on the shelf | DOI | ||
| Generation and characterization of a knock-in mouse model for spastic tetraplegia, thin corpus callosum, and progressive microcephaly (SPATCCM) | Mammalian Genome | 2023 | paper | 37,642,681 | 6 | Names the maker | PubMed |
| AJ76 and UH232 as potential agents for diagnosing early-stage Parkinson's disease | Neuropharmacology | 2023 | paper | 36,623,805 | 1 | Names the maker | PubMed |
| Prion protein lowering is a disease-modifying therapy across prion disease stages, strains and endpoints | Nucleic Acids Research | 2020 | paper | 32,776,089 | 125 | Names the maker | PubMed |
| TDP-43 mediated blood-brain barrier permeability and leukocyte infiltration promote neurodegeneration in a low-grade systemic inflammation mouse model | Journal of Neuroinflammation | 2020 | paper | 32,979,923 | 59 | Names the maker | PubMed |
instruments-2026-11-15-0.1.0
Sources 6
- iCiteCC BY 4.0
- PMC's article IDsPublic domain (US government)
- PMC's open articlesEach article's own license
- NLM's PMC Article Datasets on AWSNLM's terms
- PubMedNLM's terms
- The ConductScience storeOur own data
Each source's terms
- iCiteCC BY 4.0
- PMC's article IDsNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PMC's open articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article Datasets on AWSNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
- The ConductScience storePublic papers, short quotes, and our own products
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/instruments/v1/rotarod-test/papers